dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Puig, Noemi |
dc.contributor.author | Hernández, Miguel T. |
dc.contributor.author | González, Esther |
dc.contributor.author | de Arriba, Felipe |
dc.contributor.author | Gironella Mesa, Mercedes |
dc.contributor.author | Rosiñol, Laura |
dc.contributor.author | Oriol, Albert |
dc.date.accessioned | 2022-01-17T06:49:03Z |
dc.date.available | 2022-01-17T06:49:03Z |
dc.date.issued | 2021-05-21 |
dc.identifier.citation | Puig N, Hernández MT, Rosiñol L, González E, de Arriba F, Oriol A, et al. Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood Cancer J. 2021 May 21;11:101. |
dc.identifier.issn | 2044-5385 |
dc.identifier.uri | https://hdl.handle.net/11351/6807 |
dc.description | Mieloma; Assajos controlats aleatoris |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | Blood Cancer Journal;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mieloma múltiple - Tractament |
dc.subject | Teràpia cel·lular |
dc.subject.mesh | Multiple Myeloma |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Transplantation, Autologous |
dc.subject.mesh | Drug Therapy, Combination |
dc.title | Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41408-021-00490-8 |
dc.subject.decs | mieloma múltiple |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | trasplante autólogo |
dc.subject.decs | farmacoterapia combinada |
dc.relation.publishversion | https://doi.org/10.1038/s41408-021-00490-8 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Puig N] Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain. [Hernández MT] Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. [Rosiñol L] Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain. [González E] Hospital Universitario de Cabueñes, Gijón, Spain. [de Arriba F] Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain. [Oriol A] Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain. [Gironella M] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34021118 |
dc.identifier.wos | 000657750600003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |